EU Cyber Resilience Act — Guide for Board Director & Executive Leadership
What the CRA means for your role, your team, and your day-to-day responsibilities.
The Cyber Resilience Act introduces product liability consequences and regulatory penalties that flow up to the manufacturer level — and ultimately to its leadership. Board directors and executive leaders must understand their personal accountability, ensure adequate governance structures are in place, and make resource allocation decisions that enable the organisation to achieve and maintain conformity by December 2027. Delegating CRA compliance to engineering or legal teams without board-level oversight is itself a governance failure.
Your CRA responsibilities:
- ›Set the tone at the top for product security investment and CRA compliance culture
- ›Ensure the organisation has a board-approved CRA compliance strategy and delivery timeline
- ›Allocate sufficient budget and headcount to achieve conformity assessment by December 2027
- ›Review and approve the Declaration of Conformity as the formal act of corporate accountability
- ›Establish executive-level oversight of the Article 14 vulnerability reporting process
- ›Ensure the organisation maintains product liability insurance that covers CRA-related exposure
- ›Receive regular compliance reporting from the CISO and legal counsel on CRA readiness status
Board-level CRA accountability
The CRA establishes obligations at the level of the 'manufacturer' — a legal entity, not an individual role. This means the board of directors and senior management are accountable for ensuring the organisation meets its CRA obligations. Article 13 requires the manufacturer to put in place appropriate internal processes and governance to ensure compliance throughout the product lifecycle. Boards that treat the CRA as a purely technical matter — delegated entirely to engineering — expose the organisation to regulatory sanction for governance failures as well as technical non-conformities. Effective board-level oversight requires: a designated executive owner for CRA compliance (typically the CISO or CTO reporting to the CEO), a defined compliance roadmap with board-approved milestones, and regular board reporting on conformity status.
Liability exposure under the CRA
Non-compliance with the CRA exposes the manufacturer to administrative penalties of up to €15 million or 2.5% of global annual worldwide turnover, whichever is higher. For Class I and Class II Important Products, providing false conformity information can attract penalties of up to €20 million or 4% of turnover. Beyond direct regulatory penalties, the CRA creates an environment in which the EU Product Liability Directive — updated contemporaneously — enables consumers and businesses to claim damages from manufacturers for harm caused by defective digital products. Directors in jurisdictions where corporate liability for regulatory failures can attach to individuals personally — as is increasingly common under EU financial and data protection law — should take legal advice on their personal exposure. The CRA is not a compliance exercise that can be deferred; the risk accumulates from the application date.
Governance and reporting frameworks
Effective CRA governance requires formal structures rather than ad hoc arrangements. The board should require a quarterly CRA compliance report from the executive team covering: current product classification and conformity assessment status; status of the technical file for each product line; Article 14 notification history and any open incidents; supply chain compliance status; and any NCA communications or market surveillance activity. A cross-functional CRA steering group — including representation from legal, security, engineering, product, and finance — should meet monthly and escalate material issues to the board. The Declaration of Conformity should be reviewed and re-signed by an authorised executive at each major product release. Board committees with existing risk and audit mandates should incorporate CRA compliance into their remits.
Resource allocation for compliance
Achieving CRA conformity is not cost-free. The European Commission's impact assessment estimated that compliance costs for SMEs would average €29,000 per product and substantially more for complex products requiring notified body assessment. Boards must allocate budget to cover: SBOM tooling and integration, security testing expansion, potential penetration testing or red team exercises, technical file documentation effort, legal review of the Declaration of Conformity and associated commercial agreements, and — for Class II Important Products — notified body fees. Boards should also assess whether the organisation has the internal expertise to meet these requirements or whether specialist advisory support is needed. Investment in compliance before the December 2027 application date is substantially cheaper than responding to market surveillance action after it.
Getting started checklist
Commission an executive-level briefing from legal and security leadership on the organisation's current CRA exposure — covering which products are in scope, which classification applies, and what the current conformity gap is. Request a CRA readiness score for each in-scope product line and review it at the next board meeting. Approve a CRA compliance project with defined milestones, a budget allocation, and a named executive sponsor. Confirm that product liability insurance adequately covers CRA-era regulatory exposure and request legal advice if not. Establish a regular CRA reporting cadence into the board's audit or risk committee. Direct the CISO to confirm that Article 14 notification procedures are documented and that someone has authority to approve submissions within the 24-hour early warning window.
CVD Portal handles your CRA Article 13 obligations automatically.
Public CVD submission portal, 48-hour acknowledgment tracking, Article 14 deadline alerts, and CSAF advisory generation — built for Boards and their teams.
Start your free portalFrequently asked by Boards
Can a board delegate CRA compliance responsibility to a single executive or department?+
Operational responsibility can and should be delegated — typically to the CISO, CTO, or a dedicated regulatory affairs function. However, the board cannot delegate its oversight accountability. The manufacturer as a legal entity remains responsible for compliance, and the board's governance role requires it to set objectives, allocate resources, receive reporting, and act on compliance failures. Boards that delegate without overseeing create additional governance risk, particularly if a market surveillance investigation reveals that compliance failures persisted without board awareness.
Does the CRA affect M&A due diligence?+
Yes, significantly. Acquirers of companies that manufacture products with digital elements must assess CRA compliance as part of technical due diligence. Non-conformant products in a target company's portfolio represent regulatory risk that will transfer with the acquisition — including historical non-conformity during the transitional period if the product was placed on the market after the application date. Due diligence should cover: product classification, conformity assessment status, technical file completeness, SBOM accuracy, vulnerability management process maturity, and any history of NCA correspondence. CRA readiness should be included in M&A warranties and indemnities.
What is the board's role in the Declaration of Conformity?+
The EU Declaration of Conformity under Annex V must be signed by the manufacturer or their authorised representative. In practice, this means a duly authorised senior executive — typically the CEO, COO, or a designated officer. The board is responsible for ensuring that the person who signs the DoC has reviewed the underlying technical evidence and that the organisation's internal approval processes are documented. Signing a DoC without the supporting technical file evidence constitutes a false declaration, which attracts the highest tier of CRA penalties — up to €20 million or 4% of global turnover.
Key CRA articles for Boards
Need a CVD policy template your team can deploy today?
Free CRA-compliant templates for every stage — from first CVD policy to full PSIRT programme.